Annual D&A
$278.00 K
-$789.00 K-73.95%
31 December 2023
Summary:
Lyra Therapeutics annual depreciation & amortization is currently $278.00 thousand, with the most recent change of -$789.00 thousand (-73.95%) on 31 December 2023. During the last 3 years, it has risen by +$183.00 thousand (+192.63%). LYRA annual D&A is now -73.95% below its all-time high of $1.07 million, reached on 31 December 2022.LYRA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$39.00 K
-$106.00 K-73.10%
30 September 2024
Summary:
Lyra Therapeutics quarterly depreciation & amortization is currently $39.00 thousand, with the most recent change of -$106.00 thousand (-73.10%) on 30 September 2024. Over the past year, it has increased by +$107.00 thousand (+157.35%). LYRA quarterly D&A is now -88.86% below its all-time high of $350.00 thousand, reached on 30 September 2021.LYRA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$405.00 K
+$107.00 K+35.91%
30 September 2024
Summary:
Lyra Therapeutics TTM depreciation & amortization is currently $405.00 thousand, with the most recent change of +$107.00 thousand (+35.91%) on 30 September 2024. Over the past year, it has dropped by -$10.00 thousand (-2.41%). LYRA TTM D&A is now -66.56% below its all-time high of $1.21 million, reached on 31 March 2022.LYRA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.0% | +157.3% | -2.4% |
| 3 y3 years | +192.6% | -88.9% | -47.0% |
| 5 y5 years | +239.0% | +550.0% | +1925.0% |
LYRA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.0% | +192.6% | -88.9% | +157.3% | -66.6% | +211.5% |
| 5 y | 5 years | -74.0% | +929.6% | -88.9% | +157.3% | -66.6% | +1925.0% |
| alltime | all time | -74.0% | +929.6% | -88.9% | +157.3% | -66.6% | +4962.5% |
Lyra Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $39.00 K(-73.1%) | $405.00 K(+35.9%) |
| June 2024 | - | $145.00 K(+6.6%) | $298.00 K(+129.2%) |
| Mar 2024 | - | $136.00 K(+60.0%) | $130.00 K(-53.2%) |
| Dec 2023 | $278.00 K(-73.9%) | $85.00 K(-225.0%) | $278.00 K(-33.0%) |
| Sept 2023 | - | -$68.00 K(+195.7%) | $415.00 K(-45.5%) |
| June 2023 | - | -$23.00 K(-108.1%) | $762.00 K(-28.9%) |
| Mar 2023 | - | $284.00 K(+27.9%) | $1.07 M(+0.4%) |
| Dec 2022 | $1.07 M(+6.6%) | $222.00 K(-20.4%) | $1.07 M(-5.0%) |
| Sept 2022 | - | $279.00 K(-2.4%) | $1.12 M(-5.9%) |
| June 2022 | - | $286.00 K(+2.1%) | $1.19 M(-1.4%) |
| Mar 2022 | - | $280.00 K(+0.7%) | $1.21 M(+21.0%) |
| Dec 2021 | $1.00 M | $278.00 K(-20.6%) | $1.00 M(+31.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $350.00 K(+15.5%) | $764.00 K(+70.9%) |
| June 2021 | - | $303.00 K(+332.9%) | $447.00 K(+184.7%) |
| Mar 2021 | - | $70.00 K(+70.7%) | $157.00 K(+65.3%) |
| Dec 2020 | $95.00 K(+251.9%) | $41.00 K(+24.2%) | $95.00 K(+55.7%) |
| Sept 2020 | - | $33.00 K(+153.8%) | $61.00 K(+79.4%) |
| June 2020 | - | $13.00 K(+62.5%) | $34.00 K(+25.9%) |
| Mar 2020 | - | $8000.00(+14.3%) | $27.00 K(0.0%) |
| Dec 2019 | $27.00 K(-67.1%) | $7000.00(+16.7%) | $27.00 K(+35.0%) |
| Sept 2019 | - | $6000.00(0.0%) | $20.00 K(+42.9%) |
| June 2019 | - | $6000.00(-25.0%) | $14.00 K(+75.0%) |
| Mar 2019 | - | $8000.00 | $8000.00 |
| Dec 2018 | $82.00 K | - | - |
FAQ
- What is Lyra Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Lyra Therapeutics?
- What is Lyra Therapeutics annual D&A year-on-year change?
- What is Lyra Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly D&A year-on-year change?
- What is Lyra Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Lyra Therapeutics?
- What is Lyra Therapeutics TTM D&A year-on-year change?
What is Lyra Therapeutics annual depreciation & amortization?
The current annual D&A of LYRA is $278.00 K
What is the all time high annual D&A for Lyra Therapeutics?
Lyra Therapeutics all-time high annual depreciation & amortization is $1.07 M
What is Lyra Therapeutics annual D&A year-on-year change?
Over the past year, LYRA annual depreciation & amortization has changed by -$789.00 K (-73.95%)
What is Lyra Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of LYRA is $39.00 K
What is the all time high quarterly D&A for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly depreciation & amortization is $350.00 K
What is Lyra Therapeutics quarterly D&A year-on-year change?
Over the past year, LYRA quarterly depreciation & amortization has changed by +$107.00 K (+157.35%)
What is Lyra Therapeutics TTM depreciation & amortization?
The current TTM D&A of LYRA is $405.00 K
What is the all time high TTM D&A for Lyra Therapeutics?
Lyra Therapeutics all-time high TTM depreciation & amortization is $1.21 M
What is Lyra Therapeutics TTM D&A year-on-year change?
Over the past year, LYRA TTM depreciation & amortization has changed by -$10.00 K (-2.41%)